Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Icad Inc (ICAD) USD0.01

Sell:$9.16 Buy:$9.18 Change: $0.60 (7.01%)
NASDAQ:2.26%
Market closed |  Prices as at close on 25 September 2020 | Switch to live prices |
Sell:$9.16
Buy:$9.18
Change: $0.60 (7.01%)
Market closed |  Prices as at close on 25 September 2020 | Switch to live prices |
Sell:$9.16
Buy:$9.18
Change: $0.60 (7.01%)
Market closed |  Prices as at close on 25 September 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers. It develops and markets computer-aided detection (CAD) solutions for digital and film-based mammography systems. Its Axxent SPX Controller includes an optimized skin treatment arm customized for compatibility in confined patient treatment rooms in physician office-based facilities.

Contact details

Address:
98 Spit Brook Rd Ste 100
NASHUA
03062-5737
United States
Telephone:
+1 (603) 8825200
Website:
www.icadmed.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ICAD
ISIN:
US44934S2068
Market cap:
$196.03 million
Shares in issue:
22.90 million
Sector:
Health Care Technology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Michael Klein
    Executive Chairman of the Board, Chief Executive Officer
  • Stacey Stevens
    President
  • R. Scott Areglado
    Chief Financial Officer
  • Jonathan Go
    Chief Technology Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.